Delivering Value to Stakeholders

Vision: “Piramal Foundation transforming Health, Education, Water and social sector ecosystems through high impact solutions, thought leadership and partnerships”.

Contribution from our CSR initiatives:

54 million+

11 States
36 million Calls - HIHL
178 Mobile Health Vans
69 Telemedicine Centres



3 States
1,000+ Schools/
257 Piramal Fellows



13 States
9.19 billion litres
water dispensed
406 Purification Units
180 Water ATMs



2 States
70% Women


Piramal Udgam won the Tatva ICICI Prudential Award - Best Service Provider in New Business Acquisition - April 2015

Piramal Foundation recognised as one of India’s Best NGOs to Work for 2015, by Great Place to Work® Institute - August 2015

Piramal Sarvajal received ‘Corporate Trailblazer Award’ from Prime Minister Narendra Modi - October 2015

Piramal Sarvajal awarded Best ‘Smart Water System Implementation’ by the World CSR Congress- February 2016

Ajay Piramal received the SEN Sustainability Award in Philanthropy Category - February 2016

Piramal Swasthya awarded ‘Express Public Healthcare Award’- March 2016

In line with our purpose of 'Doing Well and Doing Good', we believe in delivering significant value to all our stakeholders including our society at large. Piramal Foundation, our CSR platform aims to transform health, education, water and social sector ecosystems through high impact and innovative solutions, thought leadership and partnerships. Some of the reputed organisations that support us in our initiatives include Harvard Graduate School of Education, New York University, Michael & Susan Dell Foundation, UNICEF and USAID. We have expanded our CSR footprints across 19 states and touched over 54 million lives.

Dr. Swati Piramal
Vice - Chairperson, PEL

Creating a high-performance culture driven by passion,
empathy and shared future goals.

Key initiatives undertaken: Since

SEEDS (Strategy for Employee Engagement & Development Support), a 3 year Human Capital Transformation project, is enabling employees to reach greater heights through a focus on talent development and focused capability building.

The ‘Career Opportunity Program’ initiative provides career opportunities to employees who seek to explore a different career path within the Piramal Group.

We have a sharp focus on strengthening the leadership pipeline by identifying high potential employees across levels, giving them differentiated development opportunities including crossfunctional and cross-business projects, experiential learning, external and internal leadership interaction sessions and technologybased blended learning solutions.

Over 6,000+ employees have been offered customised learning solutions through our in-house Learning University that offers 43 learning solutions delivered over 300+ cohorts. Partnerships with organisations such as Harvard Business Publishing, McKinsey, Towers Watson and Aon-Hewitt enable us to deliver cutting edge development experiences to our employees.

Our focus is on becoming an “Employer of Choice” through consistent efforts to nurture the spirit of entrepreneurship and overall employee well-being through policies such as Flexi-Working, Flexi-Pay, Parental Support and Learning Assistance programmes.

Since the Abbott deal, as we were constantly transforming our organisation, one of the imperative needs of our organisation was to get the best talent across levels from different sectors that can develop new businesses and consistently grow our existing businesses. We took a series of initiatives around hiring best people, developing them for effectively executing their jobs, and identifying future leaders and growing them for leadership positions. We have changed the way we look at our new and existing people, their compensation, rewards & recognition etc. Now, our HR practices are a lot more aligned with business and are much closer to industry’s best practices.

Nandini Piramal
Executive Director, PEL


Most of the top 7 global pharma companies at Pharma Solutions since last many years

Over 6,000 hospitals in the world at Critical Care

3.5 lakh outlets across ~1,500 towns in Consumer Products

Grade A real estate developers in key cities of India

Nearly all top life sciences companies at DRG. Now started providing services to payer and provider companies.

Key initiatives undertaken:

  1. Created a 3-year Roadmap for Customer Centricity
  2. Implemented mechanism to generate Customer Experience Insights :
  • Designed & rolled out automated customer satisfaction survey across businesses
  • Conducted workshops, developed customer journey mapping and identified improvement projects to enhance customer experience across sites
  • Conducted workshops, developed customer journey mapping and identified improvement projects to enhance customer experience across sites
  • Conducted regular training program to enhance employee knowledge quotient on customer centricity and enhance their engagement in customer journey mapping.
  • Governance structure created to review Customer Satisfaction Index (CSI), developed an improvement action plan and undertaken Customer experience improvement projects
  • Initiating 3600 customer view & customer data analytics, internal customer centricity certification, CX audit & scorecard, and key account analysis & customer segmentation

Won Best Customer Experience Award of the year - Pharmaceutical at Customer Fest India- February 2016.

Customer Centric Partner Award from Abbott (one of our key clients) to our Generics Team at CPhI Mumbai - December 2015.

The Company has delivered a strong track record of generating superior shareholder returns over the last three decades. Post the Abbott deal, during the phase of developing new businesses and growing the remaining Healthcare businesses, the Company has delivered outstanding shareholder returns in last five years, significantly higher than benchmarked indices.


Annualised shareholder return delivered by PEL between June 1, 2012 to May 31, 2016


Annualised return delivered by Nifty between June 1, 2012 to May 31, 2016

1. Total shareholder return numbers are as on May 31, 2016. Assumes re-investment of dividend in the stock (Source : Bloomberg)
2. Of the buy back of 41.8 mn shares shown in FY11, buyback of 0.7 mn shares happened in FY12
3. Capital returned to shareholders through dividends doesn’t include amount paid under Dividend Distribution Tax